HEMLIBRA

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: 1c8029cfd47f2953
Drug Approval Canada Name: HEMLIBRA
Product Name: HEMLIBRA
Status: Marketed
Status Date: 2019-02-21
Original Market Date: 2019-02-21
Din: 02479656
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 20:28.92
Atc Original: B02BX06 EMICIZUMAB
Atc Name: b 02 bx 06
Aig Number: 0160531002
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

EMICIZUMAB

105 MG / 0.7 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1c8029cfd47f2953

Type

Standard